| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.32 | 4e-11 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.23 | 3e-07 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.23 | 2e-06 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.2 | 6e-06 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.15 | 0.001 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.15 | 0.005 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.1 | 0.02 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.1 | 0.03 |